Global Dermatophytic Onychomycosis Treatment Market By Product (Nail Paint and Tablets), By Type (OTC and RX,) By Route Of Administration (Topical and Oral), By Distribution Channel (Healthcare, Hospitality, Commercial, Institutional, Transportation, Industrial, Remediation & Restoration, and Household), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 95278
- Number of Pages: 347
- Format:
-
keyboard_arrow_up
-
-
- Bausch Health Companies
- Celtic Pharma
- Galderma S.A.
- Johnson & Johnson
- Anacor pharmaceuticals Inc.
- Pfizer Inc.
- GlaxoSmithKline Plc
- Novartis AG
- Topica Pharmaceuticals Inc.
- Bayer AG
- Moberg Pharma AB
- Allergen Inc.
- Cipla Ltd
- Reddy’s Laboratories Ltd
- Sanofi S.A.
- Merz Pharma.
- Medimetriks Pharmaceuticals Inc.
- NovaBiotics Inc.
- ZimVie Inc.
- Wieland Dental
- Teva Pharmaceutical Industries Ltd.
- Cardinal Health Inc.
- Zimmer Biomet
- Lumenis Ltd
- Blueberry Therapeutics
- Viatris Inc.
- Valeant Pharmaceuticals International Inc.
- Almirall S.A.
- Other players.
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible